Combivent UDV vs. salbutamol UDV (2.5mg) for treatment of an acute exacerbation of asthma in children

Trial Profile

Combivent UDV vs. salbutamol UDV (2.5mg) for treatment of an acute exacerbation of asthma in children

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Mar 2008

At a glance

  • Drugs Salbutamol; Salbutamol/ipratropium bromide
  • Indications Acute asthma
  • Focus Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 07 Mar 2008 Status changed from in progress to completed, according to ClinicalTrials.gov
    • 17 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top